Changing the experience of cancer care
We are the UK’s leading private cancer specialist and we are dedicated to providing the latest evidence-based treatments from around the world, in a high quality, safe environment – because cancer is all we do.
At our new state-of-the-art centre at Bupa Cromwell Hospital in London we have the world’s most advanced radiotherapy techniques and provide specialist treatments.
The centre specialises in complex and difficult-to-treat tumours including cancers of the brain and spine, abdomen, head and neck and lung, as well as breast and prostate cancer.
It is designed around three of the latest generation systems in the world – Gamma Knife Icon, Varian Edge, MRIdian MR linac – each capable of treating a different type of cancer. Having these three machines under one roof will make our centre Europe’s most advanced radiotherapy facility.
You will receive the very best personalised care and a consultant-led treatment plan which also embraces life-changing approaches such as exercise medicine and wellbeing therapies.
Our aim is to change the way people experience cancer treatment and care and we go a little further to ensure you can achieve the best possible life outcome.
Read Mary’s story
64-year-old Mary from Staffordshire was diagnosed with advanced breast cancer in 2014 and had been treated with surgery, conventional radiotherapy and chemotherapy when a scan revealed that her cancer had unfortunately spread to her liver. Her doctors felt neither surgery or conventional radiotherapy were an option because there were three tumours throughout her liver.
Instead Mary was able to have treatment on the MRIdian – a ground-breaking new technique which targets difficult-to-treat tumours – at the GenesisCare centre in Oxford. The MRIdian is a type of linear accelerator – a machine that directs beams of energy to permanently destroy cancer cells – combined with an in-built MRI scanner.
Mary underwent a course of five sessions over two weeks, with very few side effects other than a little tenderness. After 3 months an MRI scan showed that the liver tumours were almost completely gone, and a scan at six months showed no active cancer.
Mary has since been able to work full-time in her IT consultancy and spend time gardening. Ongoing drug therapy will help maximise the possibility of controlling her cancer. She said: “After years of running away from my cancer and different therapies, I feel I’ve been thrown a lifeline by receiving this revolutionary treatment.”